Skip to content

Advances in our understanding of the pathogenesis of hemolytic uremic syndromes

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)F454-F461
JournalAJP - Renal Physiology
Volume314
Issue number3
DOIs
DateAccepted/In press - 16 Nov 2017
DatePublished (current) - 1 Mar 2018

Abstract

Hemolytic uremic syndrome (HUS) is major global health care issue as it is the leading cause of acute kidney injury in children. It is a triad of acute kidney injury, microangiopathic hemolytic anemia, and thrombocytopenia. In recent years, major advances in our understanding of complement-driven inherited rare forms of HUS have been achieved. However, in children 90% of cases of HUS are associated with a Shiga toxin-producing enteric pathogen. The precise pathological mechanisms in this setting are yet to be elucidated. The purpose of this review is to discuss advances in our understanding of the pathophysiology underlying HUS and identify the key questions yet to be answered by the scientific community.

    Research areas

  • Complement, Hemolytic uremic syndrome, Thrombotic microangiopathy

Download statistics

No data available

Documents

Documents

  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via APS at https://doi.org/10.1152/ajprenal.00376.2017 . Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 234 KB, PDF document

DOI

View research connections

Related faculties, schools or groups